Angewandte
Chemie
DOI: 10.1002/anie.201201110
Terpene Biosynthesis
The Stereochemical Course and Mechanism of the IspH Reaction**
Christian A. Citron, Nelson L. Brock, Patrick Rabe, and Jeroen S. Dickschat*
Two pathways exist for the biosynthesis of the terpene
monomers dimethylallyl diphosphate (DMAPP) and isopen-
tenyl diphosphate (IPP): the mevalonate pathway[1] and the
deoxyxylulose phosphate (DOX) pathway.[2,3] Many patho-
genic bacteria and the malaria parasite Plasmodium falcipa-
rum exclusively use the DOX pathway, which is essential in
these organisms.[4,5] Since this pathway is not present in
humans, its enzymes represent attractive targets for new
antimicrobial drugs.[6] Therefore, a detailed understanding of
the enzyme mechanisms is of high interest.
hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate (HMBPP, 7)
into an approximate 1:5 mixture of DMAPP (8) and IPP (9)
has attracted considerable interest and is still under discus-
sion. The crystal structure of IspH showed a central Fe3S4
cluster,[8] while other data were in favor of an Fe4S4 cluster.[9]
Recently, the crystal structure of IspH in the presence of its
substrate 7 was refined to a structure with an Fe4S4 cluster.[10]
The fourth labile iron center binds the substrate 7,[9d,10] as well
as potent inhibitors such as pyridine diphosphates and
alkynes.[11] Mçssbauer parameters of the substrate-free
enzyme suggested that this Fe center is coordinated by
three S and two or three other ligands (O or N) that dissociate
upon substrate binding.[9b,d]
The intermediates and enzymes of the DOX pathway
have all been identified (Scheme 1).[7] In particular, the
unique mechanism of IspH that catalyzes the conversion of 1-
Three mechanisms have been proposed for the IspH
reaction (Scheme 2). Mechanism A, suggested by Rohdich
et al. (Scheme 2A), resembles a Birch reduction of complex
10 by a one-electron transfer, protonation, and elimination of
water to the allyl radical 11, and a second electron transfer to
give the allyl anion 12. Its protonation at C-2 or C-4 results in
IPP and DMAPP, respectively.[12] This mechanism is sup-
ported by isotopic labeling experiments with substrate
analogues.[13] Mechanism B, proposed by Wang et al. (Sche-
me 2B), is based on the ENDOR spectroscopic detection of
a paramagnetic intermediate trapped in the unreactive
E126A mutant that was interpreted as a metallacyclopropane
species.[14] Alternatively, this intermediate may also be
described as an h2-alkenyl p complex. The delineated mech-
anism proceeds from 10 by one-electron reduction to form the
h2-alkenyl/metallacycle 13 followed by a protonation/dehy-
dration to give the h1-allyl complex 14. A second electron
transfer yields 12 as the precursor for IPP and DMAPP.
Mechanism C was proposed by Altincicek et al. and includes
the initial protonation/dehydration of 10 assisted by the Lewis
acidity of the metal center to generate the allyl cation 15,
which undergoes two reduction steps via 11 to 12 and
a subsequent protonation to afford IPP and DMAPP.[15]
This mechanism is contradicted by the minor effect of
electron-withdrawing substituents in substrate analogues.[16]
Common intermediates of all three mechanisms are the
initial complex 10 and the allyl anion 12. The product ratio of
IPP and DMAPP was suggested to be controlled by the
proton transfer from the terminal phosphate group of
HMBPP, where the two oxygen atoms are at a distance of
3.4–3.5 ꢀ to C-1 and C-3 (Scheme 2A).[10,12b] This hypothesis
is in full agreement with the observed stereospecific C-3
protonation of HMBPP from the Si face.[17] The stereochem-
ical course of almost all the steps of the DOX pathway have
been studied.[18] Along this pathway, the C-3 hydrogen atom
of 1 (HA, Scheme 1) becomes the aldehyde hydrogen atom in
2 and ends up as the pro-S hydrogen atom at C-1 in 3, whereas
the pro-R hydrogen atom (HC) is introduced by NADPH.[19]
All subsequent transformations from 3 to 6 proceed with an
Scheme 1. Stereochemistry of the DOX pathway. CTP=cytidine tri-
phosphate, ATP=adenosine triphosphate, ADP=adenosine diphos-
phate, CMP=cytidine monophosphate.
[*] C. A. Citron, N. L. Brock, P. Rabe, Dr. J. S. Dickschat
Institut fꢀr Organische Chemie
Technische Universitꢁt Braunschweig
Hagenring 30, 38106 Braunschweig (Germany)
E-mail: j.dickschat@tu-bs.de
[**] This work was funded by the Deutsche Forschungs-gemeinschaft
(DFG) by an Emmy-Noether Fellowship (to J.S.D.) and the Fonds
der Chemischen Industrie with a scholarship (to N.L.B.). We thank
Prof. Dr. Stefan Schulz for excellent support.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2012, 51, 4053 –4057
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4053